Ambiq Micro (NYSE:AMBQ – Get Free Report) had its price target decreased by Stifel Nicolaus from $85.00 to $70.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus‘s price objective would suggest a potential upside of 55.42% from the company’s previous close.
A number of other research firms also recently commented on AMBQ. Weiss Ratings reiterated a “sell (d-)” rating on shares of Ambiq Micro in a research note on Friday, September 25th. Citigroup restated a “neutral” rating on shares of Ambiq Micro in a research note on Tuesday, August 11th. Northland Securities set a $81.00 price objective on Ambiq Micro in a research note on Wednesday, August 12th. UBS Group reduced their target price on Ambiq Micro from $73.00 to $50.00 and set a “neutral” rating on the stock in a report on Monday, November 2nd. Finally, Jefferies Financial Group started coverage on Ambiq Micro in a research report on Wednesday, October 7th. They issued a “buy” rating and a $90.00 target price for the company. Five equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Ambiq Micro currently has an average rating of “Hold” and an average price target of $73.71.
Read Our Latest Stock Report on Ambiq Micro
Ambiq Micro Trading Down 1.6%
NYSE AMBQ opened at $45.04 on Wednesday. Ambiq Micro has a 12 month low of $22.12 and a 12 month high of $91.61. The company’s fifty day moving average price is $57.07 and its two-hundred day moving average price is $53.90.
Ambiq Micro (NYSE:AMBQ – Get Free Report) last released its earnings results on Tuesday, November 10th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.32) by $0.27. The company had revenue of $38.14 million during the quarter. Ambiq Micro had a negative net margin of 37.77% and a negative return on equity of 11.85%. Ambiq Micro has set its Q4 2026 guidance at -0.090–0.030 EPS. Analysts predict that Ambiq Micro will post -1.16 EPS for the current year.
Insider Buying and Selling at Ambiq Micro
In other news, COO Sean Chen sold 15,000 shares of Ambiq Micro stock in a transaction dated Wednesday, October 14th. The shares were sold at an average price of $51.50, for a total value of $772,500.00. Following the completion of the transaction, the chief operating officer directly owned 106,268 shares of the company’s stock, valued at approximately $5,472,802. The trade was a 12.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO Scott Hanson sold 7,000 shares of the business’s stock in a transaction dated Thursday, October 15th. The shares were sold at an average price of $51.00, for a total transaction of $357,000.00. Following the sale, the chief technology officer directly owned 212,546 shares of the company’s stock, valued at approximately $10,839,846. This represents a 3.19% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 331,887 shares of company stock valued at $19,995,954 over the last three months. 10.00% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Ambiq Micro
Several institutional investors have recently made changes to their positions in the stock. Polar Asset Management Partners Inc. raised its position in shares of Ambiq Micro by 671.8% during the 1st quarter. Polar Asset Management Partners Inc. now owns 201,335 shares of the company’s stock worth $5,116,000 after purchasing an additional 175,247 shares during the period. Wellington Management Group LLP acquired a new position in Ambiq Micro during the 2nd quarter valued at approximately $14,847,000. Atreides Management LP boosted its position in Ambiq Micro by 23.8% during the 1st quarter. Atreides Management LP now owns 862,175 shares of the company’s stock valued at $21,908,000 after purchasing an additional 165,755 shares during the period. Roubaix Capital LLC bought a new position in Ambiq Micro during the 1st quarter worth $3,197,000. Finally, Lazard Asset Management LLC bought a new position in Ambiq Micro during the 1st quarter worth $1,633,000.
Trending Headlines about Ambiq Micro
Here are the key news stories impacting Ambiq Micro this week:
- Positive Sentiment: Third-quarter revenue rose about 110% year over year to $38.14 million. The loss narrowed to $0.05 per share from $0.22 a year earlier, and the result beat analyst expectations. Ambiq Micro’s Q3 Net Loss Narrows; Revenue Jumps
- Positive Sentiment: Ambiq forecast fourth-quarter revenue of $43.5 million to $44.5 million, above the $39.6 million analyst consensus, and projected approximately $140 million in 2026 net sales. Its fourth-quarter EPS guidance also reaches a smaller loss than the consensus at the midpoint. Ambiq projects approximately $140M in 2026 net sales
- Negative Sentiment: Despite the improvement, the company continues to report losses, with a negative net margin and negative return on equity. Investors may be looking for clearer progress toward sustained profitability. Ambiq Micro reports third-quarter results
Ambiq Micro Company Profile
Ambiq Micro is a semiconductor company that develops ultra-low-power systems-on-chip and related technology for battery-powered devices. Its products are designed to help devices process data while using less energy, supporting applications that require extended battery life. The company’s offerings include Apollo microcontroller and system-on-chip products, along with software and development tools. Ambiq’s Subthreshold Power Optimized Technology (SPOT) is designed to reduce power consumption, including in devices that run artificial intelligence workloads at the edge.
Recommended Stories
- Five stocks we like better than Ambiq Micro
- The AI Debt Bill Is Coming Due, But Biotech Has Revenue to Show for the Boom
- 3 Insider Selling Stories; 3 Different Signals for Investors
- The Trade Desk Beats on Revenue, But the Fine Print Matters
- Poll Reveals: Which States Are Most Prepared for a Crisis? [2026]
Receive News & Ratings for Ambiq Micro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambiq Micro and related companies with MarketBeat.com's FREE daily email newsletter.
